메뉴 건너뛰기




Volumn 26, Issue 12, 1996, Pages 2866-2875

Inhibition of experimental autoimmune myasthenia gravis by major histocompatibility complex class II competitor peptides results not only in a suppressed but also in an altered immune response

Author keywords

Experimental autoimmune myasthenia gravis; Major histocompatibility complex competitor peptides; Peptide immunotherapy

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PEPTIDE;

EID: 0029822116     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.1830261210     Document Type: Article
Times cited : (16)

References (49)
  • 33
    • 10544235251 scopus 로고
    • Experimental autoimmune myasthenia gravis
    • Vincent, A and Wray, D, Eds. Manchester University Press, Manchester
    • de Baets, M. H., Experimental autoimmune myasthenia gravis, In: Neuromuscular transmission: basic and applied aspects. Vincent, A and Wray, D, Eds. Manchester University Press, Manchester, 1990. 13: 268.
    • (1990) Neuromuscular Transmission: Basic and Applied Aspects , vol.13 , pp. 268
    • De Baets, M.H.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.